FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003996125> ?p ?o ?g. }

• W2003996125 endingPage "2286" @default.
• W2003996125 startingPage "2277" @default.
• W2003996125 abstract "Our aim was to investigate the safety and efficacy of intravenous allogeneic human mesenchymal stem cells (hMSCs) in patients with myocardial infarction (MI).Bone marrow-derived hMSCs may ameliorate consequences of MI, and have the advantages of preparation ease, allogeneic use due to immunoprivilege, capacity to home to injured tissue, and extensive pre-clinical support.We performed a double-blind, placebo-controlled, dose-ranging (0.5, 1.6, and 5 million cells/kg) safety trial of intravenous allogeneic hMSCs (Prochymal, Osiris Therapeutics, Inc., Baltimore, Maryland) in reperfused MI patients (n=53). The primary end point was incidence of treatment-emergent adverse events within 6 months. Ejection fraction and left ventricular volumes determined by echocardiography and magnetic resonance imaging were exploratory efficacy end points.Adverse event rates were similar between the hMSC-treated (5.3 per patient) and placebo-treated (7.0 per patient) groups, and renal, hepatic, and hematologic laboratory indexes were not different. Ambulatory electrocardiogram monitoring demonstrated reduced ventricular tachycardia episodes (p=0.025), and pulmonary function testing demonstrated improved forced expiratory volume in 1 s (p=0.003) in the hMSC-treated patients. Global symptom score in all patients (p=0.027) and ejection fraction in the important subset of anterior MI patients were both significantly better in hMSCs versus placebo subjects. In the cardiac magnetic resonance imaging substudy, hMSC treatment, but not placebo, increased left ventricular ejection fraction and led to reverse remodeling.Intravenous allogeneic hMSCs are safe in patients after acute MI. This trial provides pivotal safety and provisional efficacy data for an allogeneic bone marrow-derived stem cell in post-infarction patients. (Safety Study of Adult Mesenchymal Stem Cells [MSC] to Treat Acute Myocardial Infarction; NCT00114452)." @default.
• W2003996125 created "2016-06-24" @default.
• W2003996125 creator A5010240121 @default.
• W2003996125 creator A5036131732 @default.
• W2003996125 creator A5036850247 @default.
• W2003996125 creator A5041094561 @default.
• W2003996125 creator A5043447056 @default.
• W2003996125 creator A5045816524 @default.
• W2003996125 creator A5048156911 @default.
• W2003996125 creator A5050107961 @default.
• W2003996125 creator A5050523958 @default.
• W2003996125 creator A5054589840 @default.
• W2003996125 creator A5060436966 @default.
• W2003996125 creator A5068388388 @default.
• W2003996125 creator A5072923937 @default.
• W2003996125 creator A5085774808 @default.
• W2003996125 date "2009-12-01" @default.
• W2003996125 modified "2023-10-17" @default.
• W2003996125 title "A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction" @default.
• W2003996125 cites W1965425745 @default.
• W2003996125 cites W1971375423 @default.
• W2003996125 cites W1972171120 @default.
• W2003996125 cites W1987503760 @default.
• W2003996125 cites W1993327296 @default.
• W2003996125 cites W2008031660 @default.
• W2003996125 cites W2009485059 @default.
• W2003996125 cites W2014379405 @default.
• W2003996125 cites W2015609204 @default.
• W2003996125 cites W2026749151 @default.
• W2003996125 cites W2033284503 @default.
• W2003996125 cites W2033531130 @default.
• W2003996125 cites W2035797488 @default.
• W2003996125 cites W2050974735 @default.
• W2003996125 cites W2061981400 @default.
• W2003996125 cites W2084693500 @default.
• W2003996125 cites W2087165431 @default.
• W2003996125 cites W2099021179 @default.
• W2003996125 cites W2101995250 @default.
• W2003996125 cites W2102619901 @default.
• W2003996125 cites W2104820453 @default.
• W2003996125 cites W2111486034 @default.
• W2003996125 cites W2114140981 @default.
• W2003996125 cites W2115016063 @default.
• W2003996125 cites W2119161500 @default.
• W2003996125 cites W2125078269 @default.
• W2003996125 cites W2132812618 @default.
• W2003996125 cites W2135860513 @default.
• W2003996125 cites W2150110701 @default.
• W2003996125 cites W2154088932 @default.
• W2003996125 cites W2158800431 @default.
• W2003996125 cites W2159348812 @default.
• W2003996125 cites W2167595513 @default.
• W2003996125 cites W2990123797 @default.
• W2003996125 cites W4235858444 @default.
• W2003996125 cites W4245666729 @default.
• W2003996125 cites W82442207 @default.
• W2003996125 doi "https://doi.org/10.1016/j.jacc.2009.06.055" @default.
• W2003996125 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3580848" @default.
• W2003996125 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19958962" @default.
• W2003996125 hasPublicationYear "2009" @default.
• W2003996125 type Work @default.
• W2003996125 sameAs 2003996125 @default.
• W2003996125 citedByCount "1206" @default.
• W2003996125 countsByYear W20039961252012 @default.
• W2003996125 countsByYear W20039961252013 @default.
• W2003996125 countsByYear W20039961252014 @default.
• W2003996125 countsByYear W20039961252015 @default.
• W2003996125 countsByYear W20039961252016 @default.
• W2003996125 countsByYear W20039961252017 @default.
• W2003996125 countsByYear W20039961252018 @default.
• W2003996125 countsByYear W20039961252019 @default.
• W2003996125 countsByYear W20039961252020 @default.
• W2003996125 countsByYear W20039961252021 @default.
• W2003996125 countsByYear W20039961252022 @default.
• W2003996125 countsByYear W20039961252023 @default.
• W2003996125 crossrefType "journal-article" @default.
• W2003996125 hasAuthorship W2003996125A5010240121 @default.
• W2003996125 hasAuthorship W2003996125A5036131732 @default.
• W2003996125 hasAuthorship W2003996125A5036850247 @default.
• W2003996125 hasAuthorship W2003996125A5041094561 @default.
• W2003996125 hasAuthorship W2003996125A5043447056 @default.
• W2003996125 hasAuthorship W2003996125A5045816524 @default.
• W2003996125 hasAuthorship W2003996125A5048156911 @default.
• W2003996125 hasAuthorship W2003996125A5050107961 @default.
• W2003996125 hasAuthorship W2003996125A5050523958 @default.
• W2003996125 hasAuthorship W2003996125A5054589840 @default.
• W2003996125 hasAuthorship W2003996125A5060436966 @default.
• W2003996125 hasAuthorship W2003996125A5068388388 @default.
• W2003996125 hasAuthorship W2003996125A5072923937 @default.
• W2003996125 hasAuthorship W2003996125A5085774808 @default.
• W2003996125 hasBestOaLocation W20039961251 @default.
• W2003996125 hasConcept C126322002 @default.
• W2003996125 hasConcept C142724271 @default.
• W2003996125 hasConcept C164705383 @default.
• W2003996125 hasConcept C197934379 @default.
• W2003996125 hasConcept C203092338 @default.
• W2003996125 hasConcept C204787440 @default.
• W2003996125 hasConcept C27081682 @default.

• next